A novel community health worker tool outperforms WHO clinical staging for assessment of antiretroviral therapy eligibility in a resource-limited setting

Peter MacPherson, David Lalloo, Deus Thindwa, Emily L. Webb, Bertie Squire, Geoffrey A. Chipungu, Nicola Desmond, Simon D. Makombe, Miriam Taegtmeyer, Augustine Choko, Elizabeth L. Corbett

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

The accuracy of a novel community health worker (CHW) ART eligibility assessment tool was examined in community members in Blantyre, Malawi. Nurses independently performed WHO staging and CD4 counts. 110 (55.6%) of 198 HIV-positive participants had a CD4 count of <350 cells/mm. The CHW tool significantly outperformed WHO clinical staging in identifying CD4<350 cells/mm in terms of sensitivity (41% vs. 19%), positive predictive value (75% vs. 68%), negative predictive values (53% vs. 47%) and area under the receiver-operator curve (0.62 vs. 0.54, p=0.017). Reliance on WHO staging is likely to result in missed and delayed ART initiation.

Original languageEnglish
Pages (from-to)e74-e78
JournalJournal of Acquired Immune Deficiency Syndromes
Volume65
Issue number2
DOIs
Publication statusPublished - 1 Feb 2014

Keywords

  • Africa
  • Antiretroviral therapy
  • ART eligibility
  • CD4 lymphocyte count
  • HIV
  • WHO clinical staging system

Fingerprint

Dive into the research topics of 'A novel community health worker tool outperforms WHO clinical staging for assessment of antiretroviral therapy eligibility in a resource-limited setting'. Together they form a unique fingerprint.

Cite this